Flosequinan

DB13228ApprovedWithdrawnSmall molecule

Flosequinan was approved in the USA and the UK for a year prior to being withdrawn from the market due to increased mortality in chronic heart failure patients, found in...

Formula / weight: C₁₁H₁₀FNO₂S · 239.26 g/mol (avg)

Resolves to

Compound

UNII6NB119DLU7CAS76568-02-0ChEMBLCHEMBL1908307ChEBI134972

Clinical / RWD

RxNorm25089ATCC01DB01

Structure

InChIKeyUYGONJYYUKVHDD-UHFFFAOYSA-NSMILESCN1C=C(C(=O)C2=C1C=C(F)C=C2)S(C)=O

What you can answer from here — as of July 11, 2026

3Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 6 drug categories

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Flosequinan, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account